US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Bionano Genomics Inc (BNGO)
Bionano Genomics Inc (BNGO) ニュース

BNGO

Bionano Genomics (BNGO)

Bionano Genomics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BNGO

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/01	21 : 00	GlobeNewswire Inc.	Bionano to Report First Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 8, 2024	NASDAQ:BNGO	Bionano Genomics Inc
2024/05/01	05 : 05	GlobeNewswire Inc.	Bionano to Present at the RBC Capital Markets 2024 Global Healthcare Conference	NASDAQ:BNGO	Bionano Genomics Inc
2024/04/24	21 : 00	GlobeNewswire Inc.	Bionano Announces Publication Showing OGM’s High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing	NASDAQ:BNGO	Bionano Genomics Inc
2024/04/17	21 : 00	GlobeNewswire Inc.	Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence	NASDAQ:BNGO	Bionano Genomics Inc
2024/04/11	21 : 00	GlobeNewswire Inc.	Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing	NASDAQ:BNGO	Bionano Genomics Inc
2024/04/05	02 : 44	GlobeNewswire Inc.	Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules	NASDAQ:BNGO	Bionano Genomics Inc
2024/04/03	21 : 00	GlobeNewswire Inc.	Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics	NASDAQ:BNGO	Bionano Genomics Inc
2024/04/02	21 : 00	GlobeNewswire Inc.	Bionano Announces 9 Poster Presentations and Introduces New High Throughput Stratys™ System at the American Association for Cancer Research Annual Meeting	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/19	21 : 00	GlobeNewswire Inc.	Bionano Announces Publication of a Breast Cancer Study Showing that the Number of SVs Detected with OGM May Be Related to Prognosis, Tumor Progression and Chemotherapy Resistance	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/07	22 : 00	GlobeNewswire Inc.	Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company’s New Stratys™ System	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/06	07 : 48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/06	07 : 47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/06	07 : 46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/06	07 : 44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/06	07 : 26	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/06	06 : 23	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/06	06 : 01	GlobeNewswire Inc.	Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024	NASDAQ:BNGO	Bionano Genomics Inc
2024/02/29	22 : 00	GlobeNewswire Inc.	Bionano to Present at TD Cowen’s 44th Annual Health Care Conference	NASDAQ:BNGO	Bionano Genomics Inc
2024/02/28	22 : 16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BNGO	Bionano Genomics Inc
2024/02/28	22 : 01	GlobeNewswire Inc.	Bionano to Report Fourth Quarter and Year End 2023 Financial Results and Host a Conference Call and Webcast on March 5, 2024	NASDAQ:BNGO	Bionano Genomics Inc
2024/02/28	22 : 00	GlobeNewswire Inc.	Bionano Announces Amendment to Debt Financing Arrangement to Extend Cash Runway	NASDAQ:BNGO	Bionano Genomics Inc
2024/02/22	22 : 00	GlobeNewswire Inc.	American College of Medical Genetics and Genomics Includes OGM in Latest Edition of Technical Laboratory Standards for Solid Tumor Analysis	NASDAQ:BNGO	Bionano Genomics Inc
2024/01/31	22 : 00	GlobeNewswire Inc.	Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference	NASDAQ:BNGO	Bionano Genomics Inc
2024/01/30	22 : 00	GlobeNewswire Inc.	Bionano’s Symposium 2024 Featured Presentations from its Global User Community Highlighting OGM as a Powerful Alternative to Classical Cytogenetics and Strong Complement to NGS	NASDAQ:BNGO	Bionano Genomics Inc
2024/01/24	22 : 00	GlobeNewswire Inc.	Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing	NASDAQ:BNGO	Bionano Genomics Inc
2024/01/23	22 : 00	GlobeNewswire Inc.	Bionano Announces Full Commercial Release of the Stratys™ System for High Throughput Optical Genome Mapping	NASDAQ:BNGO	Bionano Genomics Inc
2024/01/19	22 : 00	GlobeNewswire Inc.	Bionano Announces the Final Speaker Lineup for 2024 Symposium with 33 OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications	NASDAQ:BNGO	Bionano Genomics Inc
2024/01/12	06 : 01	GlobeNewswire Inc.	Bionano Announces Peer-Reviewed Publication from its Clinical Study Designed to Support OGM as Part of Standard of Care (SOC) in Genetic Disease Testing	NASDAQ:BNGO	Bionano Genomics Inc
2024/01/10	22 : 00	GlobeNewswire Inc.	Bionano Announces 2024 Symposium: Four Consecutive Days of OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications	NASDAQ:BNGO	Bionano Genomics Inc
2024/01/08	22 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BNGO	Bionano Genomics Inc

Showing the most relevant articles for your search:NASDAQ:BNGO

1 2 3 4 5 6 7 8 9 10 次へ >>

Energy Select Sector SPDR

US Dollar vs Euro

Bank of America

Invesco QQQ Trust Series 1

Financial Select Sector

Health Care Select Sector

Deutsche Telekom (QX)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約